Rice Hall James & Associates’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-114,806
| Closed | -$11.6M | – | 323 |
|
|
2021
Q3 | $11.6M | Sell |
114,806
-2,843
| -2% | -$286K | 0.43% | 64 |
|
|
2021
Q2 | $16.7M | Sell |
117,649
-17,074
| -13% | -$2.42M | 0.59% | 56 |
|
|
2021
Q1 | $13.4M | Sell |
134,723
-1,105
| -0.8% | -$110K | 0.44% | 60 |
|
|
2020
Q4 | $16.8M | Sell |
135,828
-37,464
| -22% | -$4.63M | 0.59% | 53 |
|
|
2020
Q3 | $16.9M | Buy |
173,292
+45,654
| +36% | +$4.45M | 0.68% | 46 |
|
|
2020
Q2 | $19.9M | Buy |
127,638
+26,712
| +26% | +$4.17M | 0.85% | 35 |
|
|
2020
Q1 | $14.6M | Sell |
100,926
-3,423
| -3% | -$494K | 0.81% | 38 |
|
|
2019
Q4 | $21.3M | Sell |
104,349
-2,619
| -2% | -$535K | 0.72% | 44 |
|
|
2019
Q3 | $8.59M | Sell |
106,968
-2,163
| -2% | -$174K | 0.31% | 107 |
|
|
2019
Q2 | $10.3M | Sell |
109,131
-6,787
| -6% | -$640K | 0.34% | 102 |
|
|
2019
Q1 | $9.91M | Buy |
+115,918
| New | +$9.91M | 0.32% | 108 |
|